Pitt Veronica, Lowe Dianne, Hill Sophie, Prictor Megan, Hetrick Sarah E, Ryan Rebecca, Berends Lynda
National Trauma Research Institute, The Alfred Hospital, Monash University, Melbourne, Australia.
Cochrane Database Syst Rev. 2013 Mar 28;2013(3):CD004807. doi: 10.1002/14651858.CD004807.pub2.
In mental health services, the past several decades has seen a slow but steady trend towards employment of past or present consumers of the service to work alongside mental health professionals in providing services. However the effects of this employment on clients (service recipients) and services has remained unclear.We conducted a systematic review of randomised trials assessing the effects of employing consumers of mental health services as providers of statutory mental health services to clients. In this review this role is called 'consumer-provider' and the term 'statutory mental health services' refers to public services, those required by statute or law, or public services involving statutory duties. The consumer-provider's role can encompass peer support, coaching, advocacy, case management or outreach, crisis worker or assertive community treatment worker, or providing social support programmes.
To assess the effects of employing current or past adult consumers of mental health services as providers of statutory mental health services.
We searched the Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library 2012, Issue 3), MEDLINE (OvidSP) (1950 to March 2012), EMBASE (OvidSP) (1988 to March 2012), PsycINFO (OvidSP) (1806 to March 2012), CINAHL (EBSCOhost) (1981 to March 2009), Current Contents (OvidSP) (1993 to March 2012), and reference lists of relevant articles.
Randomised controlled trials of current or past consumers of mental health services employed as providers ('consumer-providers') in statutory mental health services, comparing either: 1) consumers versus professionals employed to do the same role within a mental health service, or 2) mental health services with and without consumer-providers as an adjunct to the service.
Two review authors independently selected studies and extracted data. We contacted trialists for additional information. We conducted analyses using a random-effects model, pooling studies that measured the same outcome to provide a summary estimate of the effect across studies. We describe findings for each outcome in the text of the review with considerations of the potential impact of bias and the clinical importance of results, with input from a clinical expert.
We included 11 randomised controlled trials involving 2796 people. The quality of these studies was moderate to low, with most of the studies at unclear risk of bias in terms of random sequence generation and allocation concealment, and high risk of bias for blinded outcome assessment and selective outcome reporting.Five trials involving 581 people compared consumer-providers to professionals in similar roles within mental health services (case management roles (4 trials), facilitating group therapy (1 trial)). There were no significant differences in client quality of life (mean difference (MD) -0.30, 95% confidence interval (CI) -0.80 to 0.20); depression (data not pooled), general mental health symptoms (standardised mean difference (SMD) -0.24, 95% CI -0.52 to 0.05); client satisfaction with treatment (SMD -0.22, 95% CI -0.69 to 0.25), client or professional ratings of client-manager relationship; use of mental health services, hospital admissions and length of stay; or attrition (risk ratio 0.80, 95% CI 0.58 to 1.09) between mental health teams involving consumer-providers or professional staff in similar roles.There was a small reduction in crisis and emergency service use for clients receiving care involving consumer-providers (SMD -0.34 (95%CI -0.60 to -0.07). Past or present consumers who provided mental health services did so differently than professionals; they spent more time face-to-face with clients, and less time in the office, on the telephone, with clients' friends and family, or at provider agencies.Six trials involving 2215 people compared mental health services with or without the addition of consumer-providers. There were no significant differences in psychosocial outcomes (quality of life, empowerment, function, social relations), client satisfaction with service provision (SMD 0.76, 95% CI -0.59 to 2.10) and with staff (SMD 0.18, 95% CI -0.43 to 0.79), attendance rates (SMD 0.52 (95% CI -0.07 to 1.11), hospital admissions and length of stay, or attrition (risk ratio 1.29, 95% CI 0.72 to 2.31) between groups with consumer-providers as an adjunct to professional-led care and those receiving usual care from health professionals alone. One study found a small difference favouring the intervention group for both client and staff ratings of clients' needs having been met, although detection bias may have affected the latter. None of the six studies in this comparison reported client mental health outcomes.No studies in either comparison group reported data on adverse outcomes for clients, or the financial costs of service provision.
AUTHORS' CONCLUSIONS: Involving consumer-providers in mental health teams results in psychosocial, mental health symptom and service use outcomes for clients that were no better or worse than those achieved by professionals employed in similar roles, particularly for case management services.There is low quality evidence that involving consumer-providers in mental health teams results in a small reduction in clients' use of crisis or emergency services. The nature of the consumer-providers' involvement differs compared to professionals, as do the resources required to support their involvement. The overall quality of the evidence is moderate to low. There is no evidence of harm associated with involving consumer-providers in mental health teams.Future randomised controlled trials of consumer-providers in mental health services should minimise bias through the use of adequate randomisation and concealment of allocation, blinding of outcome assessment where possible, the comprehensive reporting of outcome data, and the avoidance of contamination between treatment groups. Researchers should adhere to SPIRIT and CONSORT reporting standards for clinical trials.Future trials should further evaluate standardised measures of clients' mental health, adverse outcomes for clients, the potential benefits and harms to the consumer-providers themselves (including need to return to treatment), and the financial costs of the intervention. They should utilise consistent, validated measurement tools and include a clear description of the consumer-provider role (eg specific tasks, responsibilities and expected deliverables of the role) and relevant training for the role so that it can be readily implemented. The weight of evidence being strongly based in the United States, future research should be located in diverse settings including in low- and middle-income countries.
在精神卫生服务领域,过去几十年里呈现出一种缓慢但稳定的趋势,即雇佣曾经或现在的服务使用者与精神卫生专业人员一起提供服务。然而,这种雇佣方式对服务对象(接受服务者)和服务本身的影响仍不明确。我们对随机试验进行了系统评价,以评估雇佣精神卫生服务使用者作为法定精神卫生服务提供者对服务对象的影响。在本评价中,这一角色被称为“消费者 - 提供者”,“法定精神卫生服务”一词指公共服务、法规或法律要求的服务,或涉及法定义务的公共服务。消费者 - 提供者的角色可以包括同伴支持、指导、宣传、病例管理或外展服务、危机干预工作者或积极社区治疗工作者,或提供社会支持项目。
评估雇佣当前或曾经的成年精神卫生服务使用者作为法定精神卫生服务提供者的效果。
我们检索了Cochrane对照试验中心注册库(CENTRAL,Cochrane图书馆2012年第3期)、MEDLINE(OvidSP)(1950年至2012年3月)、EMBASE(OvidSP)(1988年至2012年3月)、PsycINFO(OvidSP)(1806年至2012年3月)、CINAHL(EBSCOhost)(1981年至2009年3月)、《现刊目次》(OvidSP)(1993年至2012年3月)以及相关文章的参考文献列表。
将当前或曾经的精神卫生服务使用者作为法定精神卫生服务提供者(“消费者 - 提供者”)的随机对照试验,比较以下两种情况之一:1)消费者与在精神卫生服务中担任相同角色的专业人员;2)有和没有消费者 - 提供者作为服务辅助人员的精神卫生服务。
两位评价作者独立选择研究并提取数据。我们联系试验研究者获取更多信息。我们采用随机效应模型进行分析,汇总测量相同结局的研究以提供各研究效应的汇总估计值。我们在评价文本中描述每个结局的结果,考虑偏倚的潜在影响和结果的临床重要性,并参考临床专家的意见。
我们纳入了11项随机对照试验,涉及2796人。这些研究的质量为中到低,大多数研究在随机序列生成和分配隐藏方面存在偏倚风险不明确的情况,而在结局评估盲法和选择性结局报告方面存在高偏倚风险。五项试验涉及581人,比较了精神卫生服务中类似角色的消费者 - 提供者与专业人员(病例管理角色(4项试验)、促进团体治疗(1项试验))。在服务对象的生活质量(平均差(MD) -0.30,95%置信区间(CI) -0.80至0.20)、抑郁(数据未汇总)、一般精神卫生症状(标准化平均差(SMD) -0.24,95%CI -0.52至0.05)、服务对象对治疗的满意度(SMD -0.22,95%CI -0.69至0.25)、服务对象或专业人员对服务对象 - 管理者关系的评分、精神卫生服务的使用、住院次数和住院时间,或失访率(风险比0.80,95%CI 0.58至1.09)方面, 涉及消费者 - 提供者或类似角色专业人员的精神卫生团队之间没有显著差异。接受包含消费者 - 提供者护理的服务对象对危机和紧急服务的使用有小幅减少(SMD -0.34(95%CI -0.60至 -0.07))。曾经或现在提供精神卫生服务的消费者与专业人员的做法不同;他们与服务对象面对面交流的时间更多,在办公室、打电话、与服务对象的朋友和家人或在服务提供机构的时间更少。六项试验涉及2215人,比较了有或没有增加消费者 - 提供者的精神卫生服务。在心理社会结局(生活质量、赋权、功能、社会关系)、服务对象对服务提供的满意度(SMD 0.76,95%CI -0.59至2.10)和对工作人员满意度(SMD 0.18,95%CI -0.43至0.79)、出勤率(SMD 0.52(95%CI -0.07至1.11))、住院次数和住院时间,或失访率(风险比1.29,95%CI 0.72至2.31)方面,以消费者 - 提供者作为专业主导护理辅助人员的组与仅接受卫生专业人员常规护理的组之间没有显著差异。一项研究发现,在服务对象和工作人员对服务对象需求得到满足的评分方面,干预组有小幅优势,尽管检测偏倚可能影响了后者。该比较中的六项研究均未报告服务对象的精神卫生结局。两个比较组中的研究均未报告服务对象的不良结局或服务提供的财务成本数据。
在精神卫生团队中纳入消费者 - 提供者,对于服务对象的心理社会、精神卫生症状和服务使用结局而言,并不优于或差于担任类似角色的专业人员所取得的结局,特别是在病例管理服务方面。有低质量证据表明,在精神卫生团队中纳入消费者 - 提供者会使服务对象对危机或紧急服务的使用略有减少。消费者 - 提供者参与的性质与专业人员不同,支持其参与所需的资源也不同。证据的总体质量为中到低。没有证据表明在精神卫生团队中纳入消费者 - 提供者会带来危害。未来关于精神卫生服务中消费者 - 提供者的随机对照试验应通过充分随机化和分配隐藏、尽可能采用结局评估盲法、全面报告结局数据以及避免治疗组之间的交叉污染来尽量减少偏倚。研究人员应遵循临床试验的SPIRIT和CONSORT报告标准。未来的试验应进一步评估服务对象精神卫生的标准化测量指标、服务对象的不良结局、对消费者 - 提供者自身的潜在益处和危害(包括是否需要再次接受治疗)以及干预的财务成本。它们应使用一致、经过验证的测量工具,并明确描述消费者 - 提供者的角色(例如该角色的具体任务、职责和预期成果)以及该角色的相关培训,以便能够轻松实施。由于证据的权重主要基于美国,未来的研究应在包括低收入和中等收入国家在内的不同环境中进行。